Skip to main content
Log in

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Moellering RC Jr: The place of quinolones in everyday clinical practice. Chemotherapy 1996, 42, Supplement 1: 54–61.

    PubMed  Google Scholar 

  2. Allan JD Jr, Eliopoulos GM, Moellering RC Jr: Antibiotics: future directions by understanding structure-function relationships. In: Root RK, Trunkey DD, Sande MA: New surgical and medical approaches in infectious diseases. Churchill Livingstone, New York, 1987, p. 263–284.

    Google Scholar 

  3. Neu HC, Chin N: In vitro activity of the new fluoroquinolone CC-99,219. Antimicrobial Agents and Chemotherapy 1994, 38: 2615–2622.

    Google Scholar 

  4. Domagala JM: Structure-activity and structure-side-effect relationships for the quinolone antibacterials. Journal of Antimicrobial Chemotherapy 1994, 33: 685–706.

    PubMed  Google Scholar 

  5. Fuchs PC, Barry AL, Brown SD, Sewell, DL: In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 678–682.

    Google Scholar 

  6. Barry AL, Fuchs PC, Thornsberry C, McLaughlin JC, Jenkins SG, Hardy DJ, Allen SD: Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 676–678.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moellering, R.C. Introduction. Eur. J. Clin. Microbiol. Infect. Dis. 15, 669–670 (1996). https://doi.org/10.1007/BF01691156

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691156

Keywords

Navigation